跳至主要内容
临床试验/ISRCTN09944151
ISRCTN09944151已完成不适用

Second trimester termination of pregnancy, outcome after one or two day mifepristone-misoprostol interval: a randomised controlled trial

Helsinki University Hospital (Finland)0 个研究点目标入组 200 人开始时间: 2009年1月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
Female

入选标准

  • 1. Age over 18 years
  • 2. Duration of pregnancy (as verified by ultrasonography) between 12 weeks (12+1) up to 24 weeks (24+0) and approval for termination from the Finnish National Authority for Medico-legal Affairs (TEO)
  • 3. Singleton, live pregnancy
  • 4. Voluntary participation and signed approval to the study
  • 5. No intrauterine device (IUD) in utero at the time of abortion

排除标准

  • 1. Allergy to mifepristone or misoprostol
  • 2. Severe, complicated asthma
  • 3. An extrauterine pregnancy
  • 4. No common language with the investigators
  • 5. A coronary disease or high risk factors for it
  • 6. HIV or hepatitis (a smaller group having blood samples taken)

研究者

发起方
Helsinki University Hospital (Finland)

相似试验

Second trimester termination of pregnancy, outcome... | 临床试验